BAOAN DISTRICT SONGGANG DONGFANG HUAXING TOYS FTYBusiness Directories,Company Directories

Company Name: Corporate Name:	BAOAN DISTRICT SONGGANG DONGFANG HUAXING TOYS FTY
Company Title:
Company Description:
Keywords to Search:
Company Address:	Baoan District, Shenzhen, Guangdong Province,,,China
ZIP Code: Postal Code:	518105
Telephone Number:	86-755-7711176
Fax Number:	86-755-7718052
Website:
Email:
Industrial Classification:	Building & Decorating -- Construction Hardware & Tools -- Hardwares & Tools
Number of Employees:
Sales Amount:
Credit History: Credit Report:
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
SHANGHAI SONGJIANG COUNTY XINQIAOXIANG XINHUI HARDWARE TOOLS WORKS
CHENGDU CHENGHUA ELECTROMECHANICAL EQUIPMENT CO LTD
HANGZHOU ZHENCHONG ELECTROMECHANICAL EQUIPMENT HARDWARE FITTINGS FTY

Next company profile:
SHANGHAI KANGTE ELECTRIC CONTROL EQUIPMENT CORP
CHAOYANG CITY CHANGXING ENTERPRISE CORP
JIANGSHAN CITY KAIXUAN HARDWARE & TOOLS WORKS

Company News:

Lung Cancer - Medscape
Lung Cancer : Review in-depth clinical information, latest medical news, and guidelines on lung cancer, specifically small-cell lung cancer and non-small-cell lung cancer Read the latest
Small Cell Lung Cancer in 2024: Treatment Advances - Medscape
Amgen Drug Cuts Small Cell Lung Cancer Death Risk by 40%; Moving Earlier in the Disease Landscape: Understanding Adjuvant Immunotherapy for Non-Small Cell Lung Cancer 0 25 CME ABIM MOC Credits
Two Lung Cancer Drugs Recommended by EMA - Medscape
Is Consolidation Osimertinib Superior to Durvalumab in EGFR-Mutated Non–Small Cell Lung Cancer? Small Cell Lung Cancer in 2024: Treatment Advances 3090D553-9492-4563-8681-AD288FA52ACE
Advanced Non-Small Cell Lung Cancer Updates From ASCO 2024 - Medscape
Practice-changing studies in advanced non-small cell lung cancer presented at ASCO 2024 are reviewed by Dr Ticiana Leal, including the phase 3 LAURA and PALOMA-3 studies and a 5-year update of CROWN
A ‘Fool’s Errand’? Picking a Winner for Treating Early NSCLC
Is Consolidation Osimertinib Superior to Durvalumab in EGFR-Mutated Non–Small Cell Lung Cancer? Small Cell Lung Cancer in 2024: Treatment Advances 3090D553-9492-4563-8681-AD288FA52ACE
Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung . . .
Dr Narjust Florez explores the transformative shifts in the treatment landscape for early-stage non–small cell lung cancer over the years, particularly emphasizing the significant changes
Zenocutuzumab Effective Against NRG1 Fusion Cancers - Medscape
The bispecific antibody shows particularly promising results in non–small cell lung cancer (NSCLC) and pancreatic cancer patients, with responses lasting a median of 11 1 months
Why a New Inhalable Lung Cancer Treatment Is So Promising - Medscape
Non-Small Cell Lung Cancer (NSCLC) Imaging; Evolving Treatment for Small Cell Lung Cancer; Multidisciplinary Management of Stage III Lung Cancer; SLIDESHOW Brain Lesions: Summaries of 12 Cases;
Potential Drivers of LCINS - Medscape
During a plenary session at the 2024 World Congress on Lung Cancer, experts addressed the known and suspected causes of LCINS, including fallout from climate change, vaping, cannabis use, and
Evaluation and Management of Small Pulmonary Nodules - Page 3 - Medscape
Lung nodules in the right lung and in the upper lobes have a higher probability for malignancy [ 17 , 45 ] Some studies indicate that 70% of all lung cancers are located in the upper lobes